Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2025-12-31 @ 4:54 AM
Study NCT ID:
NCT01316757
Status:
COMPLETED
Last Update Posted:
2018-02-26
First Post:
2011-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
Sponsor:
Fox Chase Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-02-16
Start Date Type:
ACTUAL
Primary Completion Date:
2015-04-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-03
Completion Date Type:
ACTUAL
First Submit Date:
2011-03-08
First Submit QC Date:
None
Study First Post Date:
2011-03-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-02-23
Last Update Post Date:
2018-02-26
Last Update Post Date Type:
ACTUAL